Cargando…
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
Autores principales: | Gao, Shuai, Chen, Sujun, Han, Dong, Wang, Zifeng, Li, Muqing, Han, Wanting, Besschetnova, Anna, Liu, Mingyu, Zhou, Feng, Barrett, David, Luong, My Phu, Owiredu, Jude, Liang, Yi, Ahmed, Musaddeque, Petricca, Jessica, Patalano, Susan, Macoska, Jill A., Corey, Eva, Chen, Sen, Balk, Steven P., He, Housheng Hansen, Cai, Changmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541538/ https://www.ncbi.nlm.nih.gov/pubmed/32868907 http://dx.doi.org/10.1038/s41588-020-0681-7 |
Ejemplares similares
-
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition
por: Han, Wanting, et al.
Publicado: (2022) -
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression
por: Besschetnova, Anna, et al.
Publicado: (2023) -
Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer
por: Han, Wanting, et al.
Publicado: (2022) -
TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells
por: Zhou, Feng, et al.
Publicado: (2019) -
LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells
por: Wang, Zifeng, et al.
Publicado: (2019)